Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” ...
The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...
Large-language models are excellent for general-use AI systems, but they don’t understand pharmaceutical companies’ ...
Amit Singh is a global leader specializing in transformative AI and Master Data Management solutions. Please reach out to him on LinkedIn. In the highly regulated pharmaceutical industry, companies ...
DUBLIN--(BUSINESS WIRE)--The "Efficient Batch Record Design and Review" training has been added to ResearchAndMarkets.com's offering. This online training is designed for professionals in the ...
Linlin Sun and Xia Zheng of AFD China Intellectual Property Law Office cite two key Chinese Supreme People’s Court cases to clarify the conditions under which supplementary experimental data is ...